Literature DB >> 17952569

A novel gas phase method for the combined synthesis and coating of pharmaceutical particles.

Janne Raula1, Anna Lähde, Esko I Kauppinen.   

Abstract

PURPOSE: A novel aerosol flow reactor method for the combined gas phase synthesis and coating of particles for drug delivery has been developed.
MATERIALS AND METHODS: As an example, micron-sized salbutamol sulfate particles were produced via droplet-to-particle conversion and in-situ coated by the physical vapor deposition (PVD) of L-leucine vapor.
RESULTS: During the deposition, L-leucine vapor crystallized on the surfaces of amorphous salbutamol particles. The size of L-leucine crystallites increased with increasing vapor concentration of L-leucine. The salbutamol particles with rough L-leucine surfaces exhibited good flowability enabling to them to be dispersed into air flow without the delivery aid of coarse lactose carriers.
CONCLUSIONS: The fraction of particles smaller than 5 micrometers varied between 0.35 and 0.48 when dispersed into 60 l/min air flow having a jet Reynolds number of 30700. When the coated fine particles were blended with lactose carriers, the fine particle fraction was as high as 90%. The L-leucine coating also improved the stability of salbutamol particles when stored at 45% relative humidity atmosphere.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952569     DOI: 10.1007/s11095-007-9464-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

1.  Aerosol flow reactor method for synthesis of drug nanoparticles.

Authors:  Hannele Eerikäinen; Wiwik Watanabe; Esko I Kauppinen; P Petri Ahonen
Journal:  Eur J Pharm Biopharm       Date:  2003-05       Impact factor: 5.571

2.  Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles.

Authors:  Janne Raula; Hannele Eerikäinen; Esko I Kauppinen
Journal:  Int J Pharm       Date:  2004-10-13       Impact factor: 5.875

3.  Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive.

Authors:  P Lucas; K Anderson; U J Potter; J N Staniforth
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

4.  Effect of amino acids on the dispersion of disodium cromoglycate powders.

Authors:  Nora Y K Chew; Boris Y Shekunov; Henry H Y Tong; Albert H L Chow; Charles Savage; James Wu; Hak-Kim Chan
Journal:  J Pharm Sci       Date:  2005-10       Impact factor: 3.534

  4 in total
  6 in total

1.  Effect of surface coating with magnesium stearate via mechanical dry powder coating approach on the aerosol performance of micronized drug powders from dry powder inhalers.

Authors:  Qi Tony Zhou; Li Qu; Thomas Gengenbach; Ian Larson; Peter J Stewart; David A V Morton
Journal:  AAPS PharmSciTech       Date:  2012-11-30       Impact factor: 3.246

2.  Aerosolization, Drug Permeation and Cellular Interaction of Dry Powder Pulmonary Formulations of Corticosteroids with Hydroxypropyl-β-Cyclodextrin as a Solubilizer.

Authors:  Ville Vartiainen; Luis M Bimbo; Jouni Hirvonen; Esko I Kauppinen; Janne Raula
Journal:  Pharm Res       Date:  2016-09-07       Impact factor: 4.200

3.  Intact nanoparticulate indomethacin in fast-dissolving carrier particles by combined wet milling and aerosol flow reactor methods.

Authors:  Timo Laaksonen; Peng Liu; Antti Rahikkala; Leena Peltonen; Esko I Kauppinen; Jouni Hirvonen; Kristiina Järvinen; Janne Raula
Journal:  Pharm Res       Date:  2011-05-04       Impact factor: 4.200

4.  Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with L-leucine.

Authors:  Janne Raula; Frank Thielmann; Jarno Kansikas; Sami Hietala; Minna Annala; Jukka Seppälä; Anna Lähde; Esko I Kauppinen
Journal:  Pharm Res       Date:  2008-06-27       Impact factor: 4.200

5.  Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.

Authors:  Yoen-Ju Son; P Worth Longest; Michael Hindle
Journal:  Int J Pharm       Date:  2013-01-10       Impact factor: 5.875

6.  Structure and dissolution of L-leucine-coated salbutamol sulphate aerosol particles.

Authors:  Janne Raula; Jukka Seppälä; Jari Malm; Maarit Karppinen; Esko I Kauppinen
Journal:  AAPS PharmSciTech       Date:  2012-05-05       Impact factor: 3.246

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.